EDTUTC-4 New YorkLog in Sign up

PHAT
Phathom Pharmaceuticals, Inc. Common Stock
stockNASDAQ

Market OpenOct 5, 2026 11:55:36 AM EDT

6.78USD-2.023%(-0.14)340,589

6.7600Bid6.7900Ask0.0300Spread

PHAT News

Day breaks

04:56 PM EDTPhathom Pharmaceuticals begins Phase 3 trial for VOQUEZNA in non-erosive GERD ·

Investing.com

08:00 AM EDTPhathom Pharmaceuticals Announces Initiation of Registrational Phase 3 Study of VOQUEZNA® (vonoprazan) for As-Needed Treatment of Non-Erosive GERD ·

GlobeNewswire Inc.

10:16 AM EDTOld Friends Come Home, Smart Manufacturing Sets Sail: DFLZM and Vietnamese Partners to Build CKD Plant at CAEXPO ·

PR Newswire

07:44 PM EDTPHAT Investors Have Opportunity to Join Phathom Pharmaceuticals, Inc. Fraud Investigation with SBS Law ·

Business Wire

08:00 AM EDTPhathom Pharmaceuticals to Participate in Upcoming Investor Conferences ·

GlobeNewswire Inc.